Skip to main content
ARS Home » Midwest Area » Ames, Iowa » National Animal Disease Center » Infectious Bacterial Diseases Research » Research » Publications at this Location » Publication #218737

Title: Immune Responses in Mice to Mycobacterium avium subsp. paratuberculosis Following Vaccination with a Novel 74F Recombinant Polyprotein

item Chen, Li-hsuen
item Kathaperumal, Kumanan
item Huang, Ching-juo
item Mcdonough, Sean
item Stehman, Susan
item Akey, Bruce
item Huntley, John
item Bannantine, John
item Chang, Chao-fu
item Chang, Yung-fu

Submitted to: Vaccine
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 12/13/2007
Publication Date: 1/13/2008
Citation: Chen, L., Kathaperumal, K., Huang, C., Mcdonough, S.P., Stehman, S., Akey, B., Huntley, J., Bannantine, J.P., Chang, C., Chang, Y. 2008. Immune Responses in Mice to Mycobacterium avium subsp. paratuberculosis Following Vaccination with a Novel 74F Recombinant Polyprotein. Vaccine. 26(9):1253-1262.

Interpretive Summary: In this communication, we merged three separate proteins produced by Mycobacterium avium subsp paratuberculosis into a single, long protein called a polyprotein (termed 74F in this study). This was done using recombinant DNA techniques. The three proteins have been shown to elicit protective responses in animals against TB infection, and therefore, the hypothesis was that these proteins might also be protective against infection with Mycobacterium avium subsp paratuberculosis, the bacterium that causes Johne’s disease. We evaluated protection using mice and showed that mouse tissues did have fewer lesions and bacteria load when compared to control mice.

Technical Abstract: Johne’s Disease (JD) is a chronic infectious disease of ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP). Here, we report the cloning and expression of a 74kDa recombinant polyprotein (Map74F) and its protective efficacy against MAP infection in mice. Map74F was generated by the sequential linkage of the ORFs of the~17.6-kDa C-terminal fragment of Map3527 to the full-length ORF of Map1519, followed at the C terminus with ~14.6-kDa N-terminal portion of Map3527. Mice immunized with Map74F had a significant IgG1 response but not IgG2a. In immunized animals, the IgG1/IgG2a ratio increased until 4 wk after MAP challenge. The ratio decreased from 8 wk indicating a shift to a Th1 response. Antigen specific IFN-gamma response, CD3+ and CD4+ T cells increased significantly in immunized mice. Following challenge, MAP burden was significantly lower in liver, spleen and mesenteric lymph nodes of immunized animals compared to control animals indicating protection against MAP infection. This was further evident by the improved liver and spleen pathology of the immunized animals, which had fewer granulomas and lower numbers of acid-fast bacilli. Results of this study indicated that immunization of mice with Map74F protected mice against MAP infection.